A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Fenproporex
VTP-27999
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when VTP-27999 is combined with Candesartan.
Fenproporex
Imidapril
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Imidapril is combined with Candesartan.
Fenproporex
Enalaprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Enalaprilat is combined with Candesartan.
Fenproporex
Azilsartan medoxomil
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Azilsartan medoxomil is combined with Candesartan.
Fenproporex
Saralasin
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Saralasin is combined with Candesartan.
Fenproporex
Enalkiren
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Enalkiren is combined with Candesartan.
Fenproporex
Nebivolol
The risk or severity of hyperkalemia can be increased when Nebivolol is combined with Candesartan.
Fenproporex
Dexniguldipine
The risk or severity of hyperkalemia can be increased when Candesartan is combined with Dexniguldipine.
Fenproporex
Tetrandrine
The risk or severity of hyperkalemia can be increased when Candesartan is combined with Tetrandrine.
Fenproporex
Lomerizine
The risk or severity of hyperkalemia can be increased when Candesartan is combined with Lomerizine.
Fenproporex
Emopamil
The risk or severity of hyperkalemia can be increased when Candesartan is combined with Emopamil.
Fenproporex
Dexverapamil
The risk or severity of hyperkalemia can be increased when Candesartan is combined with Dexverapamil.
Fenproporex
Fish oil
The risk or severity of hyperkalemia can be increased when Candesartan is combined with Fish oil.
Fenproporex
WIN 55212-2
The risk or severity of hyperkalemia can be increased when Candesartan is combined with WIN 55212-2.
Fenproporex
Caroverine
The risk or severity of hyperkalemia can be increased when Caroverine is combined with Candesartan.
Fenproporex
Penfluridol
The risk or severity of hyperkalemia can be increased when Penfluridol is combined with Candesartan.
Fenproporex
Tertatolol
The risk or severity of hyperkalemia can be increased when Tertatolol is combined with Candesartan.
Fenproporex
Lidoflazine
The risk or severity of hyperkalemia can be increased when Lidoflazine is combined with Candesartan.
Fenproporex
Epanolol
The risk or severity of hyperkalemia can be increased when Epanolol is combined with Candesartan.
Fenproporex
Terodiline
The risk or severity of hyperkalemia can be increased when Terodiline is combined with Candesartan.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3